Search clinical trials for: lansoprazole

Total 258 results

Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Poland, Bulgaria, India, Canada, Peru, Russian Federation, Australia, New Zealand, Czech Republic, Slovakia, South Africa, Latvia, Lithuania, Colombia, Germany
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States
Takeda

Completed

Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States
Takeda

Completed

Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy

Gastroesophageal Reflux

United States
Takeda

Terminated

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

Duodenal Ulcer | Stomach Ulcer

Japan
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Poland, Bulgaria, India, South Africa, Canada, Peru, New Zealand, Australia, Lithuania, Slovakia, Hungary, Latvia, Germany, Czech Republic
Takeda

Completed

Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs

Duodenal Ulcer | Stomach Ulcer

Japan
Takeda

Completed

Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis

Esophagitis

United States
Takeda

Completed

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Gastroesophageal Reflux

United States
Università degli Studi di Ferrara

Unknown

Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata (GENIOUS)

Coronary Stenting

Italy
Il-Yang Pharm. Co., Ltd.

Completed

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

GERD | Erosive Esophagitis

Korea, Republic of
Deva Holding A.S.
TC Erciyes University; TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic...

Completed

Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication

Helicobacter Pylori Infection

Turkey
Seoul National University Hospital

Completed

The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Korea, Republic of
AstraZeneca

Completed

Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

Healthy

United States
Takeda

Completed

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Gastroesophageal Reflux

United States
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

United States
Takeda

Completed

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects

Healthy

United States
Advanced Center for Specialty Care
Takeda

Unknown

Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy

Laryngopharyngeal Reflux | Hypertrophy of Lingual Tonsil

United States
Novartis

Completed

Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn

Heartburn

United States
Emory University

Unknown

A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.

Asthma

United States
University of Southern California

Completed

Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers

Peptic Ulcer Hemorrhage

United States
AstraZeneca

Completed

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease | Heartburn
Arkansas Children's Hospital Research Institute

Completed

Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis

Cystic Fibrosis

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions

Healthy

India
Procter and Gamble

Completed

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Replicate Food Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Study

Healthy

United States
Head and Neck Surgery Associates

Completed

Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease

Gastroesophageal Reflux | Nasal Polyps

United States
Takeda

Completed

A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.

Gastroesophageal Reflux Disease
Takeda

Completed

A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease
Takeda

Completed

The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux

Gastroesophageal Reflux Disease

Poland, United States
Takeda

Completed

A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin

Osteoarthritis | Peptic Ulcer
Takeda

Completed

Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis

Esophagitis | Reflux
Taipei Veterans General Hospital, Taiwan

Unknown

Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor

Peptic Ulcer | Ulcer Complications

Taiwan
Novartis

Completed

Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn

Heartburn

United States
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
National Taiwan University Hospital

Withdrawn

Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome

Functional Dyspepsia | Epigastric Pain Syndrome | Post Prandial Distress Syndrome

Taiwan
Novartis

Completed

Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

Frequent Heartburn

United States
Lotung Poh-Ai Hospital
Tomorrow Medical Foundation

Completed

Lansoprazole Versus Mosapride for Functional Dyspepsia

Functional Dyspepsia | Epigastric Pain Syndrome | Post Prandial Distress Syndrome

Taiwan
Istanbul University

Completed

The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy

Glomerulonephritis | Nephrotic Syndrome | Membranous Nephropathy

Turkey
Korean College of Helicobacter and Upper Gastrointestinal...

Unknown

H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection

Ulcer

Korea, Republic of
Lotung Poh-Ai Hospital
Tomorrow Medical Foundation

Completed

Role of Mosapride in Patients With Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Taiwan
AstraZeneca

Completed

A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis

Erosive Esophagitis
AstraZeneca

Completed

Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

Erosive Esophagitis
AstraZeneca

Completed

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

Barrett's Esophagus

United States
AstraZeneca

Completed

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Gastroesophageal Reflux Disease

United States, Puerto Rico
Pharmaceutical Research Network

Completed

Cosopt Versus Xalacom

Ocular Hypertension | Open-Angle Glaucoma

Canada, Slovenia

3

Subscribe